Chemoinformaics analysis of 4-Methyl-2,3-dihydrofuran
| Molecular Weight | 84.118 | nRot | 0 |
| Heavy Atom Molecular Weight | 76.054 | nRig | 5 |
| Exact Molecular Weight | 84.0575 | nRing | 1 |
| Solubility: LogS | 0.017 | nHRing | 1 |
| Solubility: LogP | 0.225 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 14 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 6 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 5 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 14.4863 |
| nHD | 0 | BPOL | 9.76166 |
| QED | 0.43 |
| Synth | 3.622 |
| Natural Product Likeliness | 1.072 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.039 |
| HIA | 0.003 |
| CACO-2 | -4.243 |
| MDCK | 0.0000262 |
| BBB | 0.978 |
| PPB | 0.225836 |
| VDSS | 1.537 |
| FU | 0.859524 |
| CYP1A2-inh | 0.835 |
| CYP1A2-sub | 0.72 |
| CYP2c19-inh | 0.319 |
| CYP2c19-sub | 0.822 |
| CYP2c9-inh | 0.036 |
| CYP2c9-sub | 0.432 |
| CYP2d6-inh | 0.2 |
| CYP2d6-sub | 0.65 |
| CYP3a4-inh | 0.044 |
| CYP3a4-sub | 0.354 |
| CL | 6.522 |
| T12 | 0.8 |
| hERG | 0.032 |
| Ames | 0.573 |
| ROA | 0.024 |
| SkinSen | 0.753 |
| Carcinogencity | 0.941 |
| EI | 0.982 |
| Respiratory | 0.116 |
| NR-Aromatase | 0.004 |
| Antiviral | No |
| Prediction | 0.956861 |